William C. Bertrand's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 207,000 Ordinary Shares with a nominal value of GBP0.001 per share done at an average price of $0.0 . Disclosure was reported to the exchange on Aug. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.01 per share. | 28 Aug 2025 | 207,000 | 986,352 (0%) | 0% | 0.0 | 2,091 | Ordinary Shares with a nominal value of GBP0.001 per share |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 54,059 | 54,059 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 41,551 | 290,707 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 19,390 | 249,156 (0%) | 0% | 0 | Common Stock | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 5,471 | 7,623 (0%) | 0% | 0.6 | 3,216 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 11,023 | 229,766 (0%) | 0% | 0 | Common Stock | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 13,599 | 20,201 (0%) | 0% | 0.7 | 9,152 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 4,681 | 7,023 (0%) | 0% | 0.8 | 3,698 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 5,220 | 7,874 (0%) | 0% | 0.9 | 4,458 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics PLC (ADR) | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 49,237 | 49,237 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 16,581 | 218,743 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 118,613 | 202,162 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 32,765 | 32,765 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,891 | 83,549 (0%) | 0% | 0 | Common Stock |